My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 153

    1.

    Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines.

    Amarillo ML, Belizario VY Jr, Sadiang-Abay JT, Sison SA, Dayag AM.

    Parasit Vectors. 2008 May 27;1(1):14.PMID: 18505577 [PubMed - in process]Related articlesFree article

    2.

    Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.

    Krentel A, Fischer P, Manoempil P, Supali T, Servais G, Rückert P.

    Trop Med Int Health. 2006 Nov;11(11):1731-40.PMID: 17054754 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis.

    Ramaiah KD, Vijay Kumar KN, Ravi R, Das PK.

    Ann Trop Med Parasitol. 2005 Apr;99(3):243-52.PMID: 15829134 [PubMed - indexed for MEDLINE]Related articles

    4.

    Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.

    Lahariya C, Mishra A.

    J Vector Borne Dis. 2008 Dec;45(4):313-20.PMID: 19248659 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala.

    Aswathy S, Beteena K, Leelamoni K.

    Ann Trop Med Parasitol. 2009 Oct;103(7):617-24.PMID: 19825283 [PubMed - in process]Related articles

    6.

    National mass drug administration costs for lymphatic filariasis elimination.

    Goldman AS, Guisinger VH, Aikins M, Amarillo ML, Belizario VY, Garshong B, Gyapong J, Kabali C, Kamal HA, Kanjilal S, Kyelem D, Lizardo J, Malecela M, Mubyazi G, Nitièma PA, Ramzy RM, Streit TG, Wallace A, Brady MA, Rheingans R, Ottesen EA, Haddix AC.

    PLoS Negl Trop Dis. 2007 Oct 31;1(1):e67.PMID: 17989784 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?]

    Chanteau S, Roux JF.

    Bull Soc Pathol Exot. 2008 Jun;101(3):254-60. French. PMID: 18681220 [PubMed - indexed for MEDLINE]Related articles

    8.

    Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence.

    Washington CH, Radday J, Streit TG, Boyd HA, Beach MJ, Addiss DG, Lovince R, Lovegrove MC, Lafontant JG, Lammie PJ, Hightower AW.

    Filaria J. 2004 May 5;3(1):3.PMID: 15128461 [PubMed - as supplied by publisher]Related articlesFree article

    9.

    Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti.

    Mathieu E, Lammie PJ, Radday J, Beach MJ, Streit T, Wendt J, Addiss DG.

    Ann Trop Med Parasitol. 2004 Oct;98(7):703-14.PMID: 15509424 [PubMed - indexed for MEDLINE]Related articles

    10.

    Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience.

    Nandha B, Sadanandane C, Jambulingam P, Das P.

    Filaria J. 2007 Aug 24;6:7.PMID: 17718908 [PubMed]Related articlesFree article

    11.

    Qualitative analysis of the impact of a lymphatic filariasis elimination programme using mass drug administration on Misima Island, Papua New Guinea.

    Wynd S, Carron J, Selve B, Leggat PA, Melrose W, Durrheim DN.

    Filaria J. 2007 Jan 1;6:1.PMID: 17196113 [PubMed]Related articlesFree article

    12.

    Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India.

    Rath K, Nath N, Shaloumy M, Swain BK, Suchismita M, Babu BV.

    Trop Biomed. 2006 Dec;23(2):156-62.PMID: 17322817 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Long-term population migration: an important aspect to be considered during mass drug administration for elimination of lymphatic filariasis.

    Sunish IP, Rajendran R, Mani TR, Gajanana A, Reuben R, Satyanarayana K.

    Trop Med Int Health. 2003 Apr;8(4):316-21.PMID: 12667150 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Defining the cost of the Egyptian lymphatic filariasis elimination programme.

    Ramzy RM, Goldman AS, Kamal HA.

    Filaria J. 2005 Aug 2;4:7.PMID: 16076397 [PubMed]Related articlesFree article

    15.

    A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage.

    Ramaiah KD, Vijay Kumar KN, Hosein E, Krishnamoorthy P, Augustin DJ, Snehalatha KS, Nanda B, Das PK.

    Ann Trop Med Parasitol. 2006 Jun;100(4):345-61.PMID: 16762115 [PubMed - indexed for MEDLINE]Related articles

    16.

    Community's knowledge and perceptions about filarial elephantiasis and hydrocele in coastal Orissa, India.

    Rath K, Nayak AN, Babu BV.

    Asia Pac J Public Health. 2007;19(1):28-33.PMID: 17784656 [PubMed - indexed for MEDLINE]Related articles

    17.

    Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka.

    Weerasooriya MV, Yahathugoda CT, Wickramasinghe D, Gunawardena KN, Dharmadasa RA, Vidanapathirana KK, Weerasekara SH, Samarawickrema WA.

    Filaria J. 2007 Nov 15;6:11.PMID: 18005398 [PubMed]Related articlesFree article

    18.

    Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.

    De Rochars MB, Direny AN, Roberts JM, Addiss DG, Radday J, Beach MJ, Streit TG, Dardith D, Lafontant JG, Lammie PJ.

    Am J Trop Med Hyg. 2004 Oct;71(4):466-70.PMID: 15516644 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The global programme to eliminate lymphatic filariasis: health impact after 8 years.

    Ottesen EA, Hooper PJ, Bradley M, Biswas G.

    PLoS Negl Trop Dis. 2008 Oct 8;2(10):e317.PMID: 18841205 [PubMed - in process]Related articlesFree article

    20.

    Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.

    Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD, Weil GJ.

    Lancet. 2006 Mar 25;367(9515):992-9. Erratum in: Lancet. 2006 Jun 17;367(9527):1980. PMID: 16564361 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk